在遗传性蛋白C缺乏症中,内皮依赖蛋白C激活
Nadine Schwarz1, Hannah L McRae1, Sara Reda1,2
1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
Thrombosis and haemostasis
|April 10, 2025
概括
遗传性蛋白C缺乏症 (PCD) 损害了血液凝块的预防. 使用内皮细胞的新测定揭示了PCD患者活性蛋白C (APC) 生成的减少,为血栓形成风险评估提供了见解.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 在内皮细胞上激活蛋白C (PC) 是一个关键的抗血栓性过程.
- 遗传性PC缺陷 (PCD),由于PROC基因突变,增加了血栓友爱的风险.
- 之前的研究缺乏内皮细胞参与评估PC激活.
研究的目的:
- 评估PCD患者的激活蛋白C (APC) 生成,使用一种新的基于内皮细胞的测定方法.
- 评估PROC突变对APC生成的功能影响.
- 探索对血栓形成风险分层的潜在应用.
主要方法:
- 分析了21名PCD患者和24名对照组的血.
- 使用人类静脉内皮细胞 (HUVEC) 启动内皮依赖的APC生成.
- 通过基于寡核酸的测定和曲线下的计算面积 (AUC) 来量化APC水平.
主要成果:
- 与对照组 (1.83 nmol/L) 相比,PCD患者的平均峰值APC水平 (0.75 nmol/L) 显著降低.
- 在38%的PCD患者中,APC的AUC低于参考范围,这表明基因生成受损.
- 试验显示了标准PC试验无法检测到的功能差异.
结论:
- 这种基于内皮细胞的新型试验有效地证明了PCD中的功能APC生成缺陷.
- 结果强调了内皮细胞在PC激活和血栓形成风险评估中的重要性.
- 这种测定可能有助于个性化治疗和改进血栓形成风险评估.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
568
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
568
01:20Extrinsic and Intrinsic Pathways of Hemostasis
4.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.2K
01:27Complement System
1.9K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
1.9K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K
01:24Caspases
11.5K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
11.5K
01:24Disorders of Hemostasis
658
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
658